| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | Apr 01, 2024 | Sale | $24.38 | 5,000 | 121,913 | 263,706 | Apr 03, 2024, 06:55 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Mar 13, 2024 | Sale | $28.33 | 723 | 20,483 | 77,692 | Mar 15, 2024, 04:45 PM | |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | Mar 13, 2024 | Sale | $28.33 | 724 | 20,511 | 49,630 | Mar 15, 2024, 04:44 PM | |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | Mar 13, 2024 | Sale | $28.33 | 1,969 | 55,782 | 589,447 | Mar 15, 2024, 04:43 PM | |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | Mar 13, 2024 | Sale | $28.33 | 651 | 18,443 | 268,306 | Mar 15, 2024, 04:42 PM | |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Mar 13, 2024 | Sale | $28.33 | 619 | 17,536 | 182,558 | Mar 15, 2024, 04:42 PM | |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | Mar 04, 2024 | Sale | $25.02 | 150,000 | 3,753,125 | 666,416 | Mar 06, 2024, 08:14 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Mar 04, 2024 | Option Exercise | $24.72 | 41,292 | 1,020,851 | 99,061 | Mar 06, 2024, 08:13 PM | |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | Mar 01, 2024 | Option Exercise | $0.62 | 83,321 | 51,242 | 268,957 | Mar 05, 2024, 05:16 PM | |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | Dec 27, 2023 | Option Exercise | $15.18 | 10,828 | 164,369 | 190,545 | Dec 29, 2023, 08:30 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Dec 14, 2023 | Sale | $20.76 | 597 | 12,394 | 77,910 | Dec 18, 2023, 08:49 PM | |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | Dec 14, 2023 | Sale | $20.76 | 611 | 12,684 | 50,354 | Dec 18, 2023, 08:40 PM | |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | Dec 14, 2023 | Sale | $20.76 | 543 | 11,273 | 185,131 | Dec 18, 2023, 08:39 PM | |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | Dec 14, 2023 | Sale | $20.76 | 1,628 | 33,797 | 550,911 | Dec 18, 2023, 08:37 PM | |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Dec 14, 2023 | Sale | $20.76 | 514 | 10,671 | 182,672 | Dec 18, 2023, 08:29 PM | |
| AKRO | Akero Therapeutics, Inc. | Graham G. Walmsley | Director | Dec 08, 2023 | Buy | $19.83 | 100,000 | 1,982,940 | 800,000 | Dec 11, 2023, 09:06 PM | |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | Dec 07, 2023 | Option Exercise | $13.19 | 13,400 | 176,737 | 467,698 | Dec 11, 2023, 08:59 PM | |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | Dec 08, 2023 | Option Exercise | $13.18 | 25,746 | 339,443 | 473,871 | Dec 11, 2023, 08:59 PM | |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | Dec 11, 2023 | Option Exercise | $13.19 | 14,810 | 195,368 | 559,944 | Dec 11, 2023, 08:59 PM | |
| AKRO | Akero Therapeutics, Inc. | Graham G. Walmsley | Director | Nov 30, 2023 | Buy | $16.90 | 50,000 | 844,835 | 650,000 | Dec 05, 2023, 08:37 AM | |
| AKRO | Akero Therapeutics, Inc. | Graham G. Walmsley | Director | Dec 01, 2023 | Buy | $16.99 | 50,000 | 849,730 | 700,000 | Dec 05, 2023, 08:37 AM | |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | Nov 17, 2023 | Sale | $14.68 | 30,000 | 440,259 | 153,177 | Nov 21, 2023, 05:30 PM | |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | Oct 02, 2023 | Sale | $27.14 | 50,000 | 1,356,827 | 485,998 | Oct 04, 2023, 08:41 PM | |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | Oct 02, 2023 | Option Exercise | $36.10 | 980 | 35,378 | 183,667 | Oct 04, 2023, 08:33 PM | |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | Sep 13, 2023 | Sale | $50.34 | 1,682 | 84,672 | 460,998 | Sep 25, 2023, 08:36 PM | |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | Sep 13, 2023 | Sale | $50.34 | 632 | 31,815 | 18,468 | Sep 25, 2023, 08:31 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Sep 13, 2023 | Sale | $50.34 | 617 | 31,060 | 46,010 | Sep 25, 2023, 08:31 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Sep 21, 2023 | Sale | $27.22 | 10,000 | 272,156 | 51,010 | Sep 25, 2023, 08:31 PM | |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Sep 13, 2023 | Sale | $50.34 | 531 | 26,731 | 150,689 | Sep 25, 2023, 08:30 PM | |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | Sep 13, 2023 | Sale | $50.34 | 562 | 28,291 | 183,177 | Sep 25, 2023, 08:28 PM | |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | Sep 01, 2023 | Option Exercise | $28.06 | 50,000 | 1,403,248 | 487,680 | Sep 18, 2023, 06:48 PM | |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | Aug 30, 2023 | Option Exercise | $0.62 | 15,000 | 9,225 | 462,680 | Aug 30, 2023, 07:04 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Aug 28, 2023 | Sale | $28.17 | 11,490 | 323,729 | 52,372 | Aug 30, 2023, 07:04 PM | |
| AKRO | Akero Therapeutics, Inc. | Graham G. Walmsley | Director | Aug 08, 2023 | Buy | $42.06 | 25,000 | 1,051,475 | 600,000 | Aug 10, 2023, 04:46 PM | |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | Aug 01, 2023 | Sale | $24.76 | 50,000 | 1,237,867 | 472,680 | Aug 03, 2023, 04:13 PM | |
| AKRO | Akero Therapeutics, Inc. | Graham G. Walmsley | Director | Jul 28, 2023 | Buy | $42.69 | 30,000 | 1,280,709 | 550,000 | Aug 01, 2023, 07:52 PM | |
| AKRO | Akero Therapeutics, Inc. | Graham G. Walmsley | Director | Aug 01, 2023 | Buy | $43.26 | 25,000 | 1,081,525 | 575,000 | Aug 01, 2023, 07:52 PM | |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | Jul 03, 2023 | Sale | $25.62 | 50,000 | 1,281,041 | 472,680 | Jul 06, 2023, 08:44 PM | |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | Jun 27, 2023 | Option Exercise | $0.62 | 40,000 | 24,600 | 447,680 | Jun 27, 2023, 07:12 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Jun 21, 2023 | Sale | $52.26 | 11,349 | 593,095 | 68,627 | Jun 23, 2023, 08:06 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Jun 22, 2023 | Sale | $52.18 | 11,000 | 573,935 | 57,627 | Jun 23, 2023, 08:06 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Jun 23, 2023 | Sale | $50.76 | 11,000 | 558,360 | 47,127 | Jun 23, 2023, 08:06 PM | |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | Jun 20, 2023 | Option Exercise | $33.06 | 38,277 | 1,265,392 | 39,877 | Jun 22, 2023, 05:20 PM | |
| AKRO | Akero Therapeutics, Inc. | Heyman Tomas J. | Director | Jun 16, 2023 | Option Exercise | $39.86 | 52,000 | 2,072,569 | 26,000 | Jun 21, 2023, 05:54 PM | |
| AKRO | Akero Therapeutics, Inc. | Henderson Jane | Director | Jun 16, 2023 | Sale | $30.59 | 80,000 | 2,447,085 | 40,000 | Jun 21, 2023, 05:47 PM | |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Jun 16, 2023 | Sale | $36.45 | 118,200 | 4,308,466 | 229,420 | Jun 21, 2023, 05:46 PM | |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | Jun 13, 2023 | Sale | $55.16 | 606 | 33,427 | 22,377 | Jun 15, 2023, 09:41 PM | |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President & CEO | Jun 13, 2023 | Sale | $55.16 | 1,613 | 88,973 | 407,680 | Jun 15, 2023, 09:38 PM | |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Jun 13, 2023 | Sale | $55.16 | 509 | 28,076 | 189,420 | Jun 15, 2023, 09:35 PM | |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | Jun 13, 2023 | Sale | $55.16 | 538 | 29,676 | 183,739 | Jun 15, 2023, 09:35 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Jun 13, 2023 | Sale | $55.16 | 591 | 32,600 | 79,976 | Jun 15, 2023, 09:29 PM | |
| AKRO | Akero Therapeutics, Inc. | Graham G. Walmsley | Director | Sep 19, 2022 | Buy | $26.00 | 400,000 | 10,400,000 | 400,000 | Jun 15, 2023, 09:26 PM | |
| AKRO | Akero Therapeutics, Inc. | Graham G. Walmsley | Director | May 19, 2023 | Buy | $42.00 | 120,000 | 5,040,000 | 520,000 | Jun 15, 2023, 09:26 PM | |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | Jun 01, 2023 | Sale | $23.28 | 50,000 | 1,163,889 | 434,293 | Jun 05, 2023, 06:23 PM | |
| AKRO | Akero Therapeutics, Inc. | Graham G. Walmsley | Director | Sep 19, 2023 | Buy | $26.00 | 400,000 | 10,400,000 | 400,000 | May 23, 2023, 09:55 PM | |
| AKRO | Akero Therapeutics, Inc. | Graham G. Walmsley | Director | May 19, 2023 | Buy | $42.00 | 120,000 | 5,040,000 | 520,000 | May 23, 2023, 09:55 PM | |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President & CEO | Apr 18, 2023 | Option Exercise | $0.62 | 40,000 | 24,600 | 409,293 | May 03, 2023, 08:28 PM | |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President & CEO | May 01, 2023 | Sale | $22.84 | 50,000 | 1,142,235 | 434,293 | May 03, 2023, 08:28 PM | |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President & CEO | Apr 03, 2023 | Sale | $19.28 | 50,000 | 963,951 | 394,293 | Apr 05, 2023, 04:55 PM | |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | Mar 10, 2023 | Option Exercise | $43.47 | 641 | 27,864 | 22,983 | Mar 14, 2023, 04:25 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Mar 10, 2023 | Option Exercise | $43.46 | 701 | 30,465 | 80,567 | Mar 14, 2023, 04:20 PM | |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | Mar 10, 2023 | Option Exercise | $43.47 | 634 | 27,560 | 184,277 | Mar 14, 2023, 04:19 PM | |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Mar 10, 2023 | Option Exercise | $43.47 | 603 | 26,212 | 189,929 | Mar 14, 2023, 04:19 PM | |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President & CEO | Mar 10, 2023 | Option Exercise | $43.47 | 1,706 | 74,160 | 369,293 | Mar 14, 2023, 04:18 PM | |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President & CEO | Feb 01, 2023 | Sale | $24.84 | 50,000 | 1,241,770 | 395,999 | Feb 03, 2023, 05:25 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Jan 13, 2023 | Sale | $50.53 | 5,000 | 252,651 | 85,220 | Jan 18, 2023, 05:30 PM | |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President & CEO | Jan 03, 2023 | Sale | $25.94 | 50,000 | 1,297,126 | 395,999 | Jan 05, 2023, 06:46 PM | |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | Jan 03, 2023 | Sale | $27.63 | 17,554 | 484,958 | 193,688 | Jan 05, 2023, 05:56 PM | |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Dec 28, 2022 | Option Exercise | $39.18 | 3,400 | 133,201 | 204,732 | Dec 30, 2022, 04:26 PM | |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Dec 29, 2022 | Sale | $44.74 | 28,132 | 1,258,702 | 210,848 | Dec 30, 2022, 04:26 PM | |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | Dec 28, 2022 | Option Exercise | $28.39 | 1,998 | 56,716 | 24,623 | Dec 29, 2022, 05:41 PM | |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | Dec 27, 2022 | Option Exercise | $28.39 | 38,002 | 1,078,787 | 42,625 | Dec 29, 2022, 05:41 PM | |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | Dec 27, 2022 | Option Exercise | $27.80 | 25,000 | 694,961 | 194,949 | Dec 28, 2022, 06:30 PM | |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President & CEO | Dec 16, 2022 | Option Exercise | $0.62 | 8,500 | 5,228 | 370,999 | Dec 20, 2022, 07:46 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Dec 12, 2022 | Sale | $43.23 | 5,000 | 216,137 | 86,670 | Dec 13, 2022, 08:24 PM | |
| AKRO | Akero Therapeutics, Inc. | Montrago Trustees Ltd | Former 10% owner | Dec 01, 2022 | Sale | $43.50 | 1,636,000 | 71,166,000 | 3,271,829 | Dec 05, 2022, 04:36 PM | |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President & CEO | Dec 01, 2022 | Sale | $23.34 | 20,000 | 466,850 | 320,148 | Dec 02, 2022, 05:52 PM | |
| AKRO | Akero Therapeutics, Inc. | Harrison Seth Loring | Director | Nov 30, 2022 | Sale | $46.94 | 11,101 | 521,067 | 141,080 | Dec 02, 2022, 05:48 PM | |
| AKRO | Akero Therapeutics, Inc. | Harrison Seth Loring | Director | Nov 30, 2022 | Sale | $46.94 | 12,030 | 564,673 | 153,242 | Dec 02, 2022, 05:48 PM | |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Nov 15, 2022 | Sale | $45.04 | 3,138 | 141,343 | 187,784 | Nov 16, 2022, 07:15 PM | |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Nov 16, 2022 | Sale | $45.47 | 3,947 | 179,464 | 183,937 | Nov 16, 2022, 07:15 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Nov 10, 2022 | Sale | $39.42 | 5,000 | 197,105 | 72,173 | Nov 14, 2022, 05:26 PM | |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President & CEO | Nov 01, 2022 | Sale | $22.02 | 20,000 | 440,333 | 320,148 | Nov 02, 2022, 09:52 PM | |
| AKRO | Akero Therapeutics, Inc. | Harrison Seth Loring | Director | Oct 28, 2022 | Sale | $40.31 | 21,138 | 852,091 | 148,202 | Nov 01, 2022, 05:38 PM | |
| AKRO | Akero Therapeutics, Inc. | Harrison Seth Loring | Director | Oct 28, 2022 | Sale | $40.31 | 22,965 | 925,738 | 160,962 | Nov 01, 2022, 05:38 PM | |
| AKRO | Akero Therapeutics, Inc. | Harrison Seth Loring | Director | Oct 27, 2022 | Sale | $41.53 | 66,426 | 2,758,920 | 194,063 | Oct 27, 2022, 09:50 PM | |
| AKRO | Akero Therapeutics, Inc. | Harrison Seth Loring | Director | Oct 27, 2022 | Sale | $41.53 | 72,172 | 2,997,575 | 210,790 | Oct 27, 2022, 09:50 PM | |
| AKRO | Akero Therapeutics, Inc. | Harrison Seth Loring | Director | Oct 25, 2022 | Sale | $44.92 | 4,515 | 202,797 | 300,851 | Oct 27, 2022, 09:50 PM | |
| AKRO | Akero Therapeutics, Inc. | Harrison Seth Loring | Director | Oct 25, 2022 | Sale | $44.92 | 4,906 | 220,359 | 326,813 | Oct 27, 2022, 09:50 PM | |
| AKRO | Akero Therapeutics, Inc. | Harrison Seth Loring | Director | Oct 26, 2022 | Sale | $43.75 | 65,885 | 2,882,142 | 264,991 | Oct 27, 2022, 09:50 PM | |
| AKRO | Akero Therapeutics, Inc. | Harrison Seth Loring | Director | Oct 26, 2022 | Sale | $43.75 | 71,583 | 3,131,402 | 287,852 | Oct 27, 2022, 09:50 PM | |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Oct 26, 2022 | Sale | $45.03 | 4,762 | 214,433 | 190,922 | Oct 27, 2022, 09:27 PM | |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Oct 25, 2022 | Sale | $28.25 | 20,653 | 583,465 | 206,337 | Oct 27, 2022, 09:27 PM | |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | Oct 25, 2022 | Option Exercise | $25.54 | 25,000 | 638,444 | 175,754 | Oct 27, 2022, 09:25 PM | |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Sep 13, 2022 | Option Exercise | $22.16 | 32,500 | 720,150 | 256,337 | Oct 27, 2022, 09:23 PM | |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | Oct 13, 2022 | Option Exercise | $23.41 | 40,000 | 936,580 | 24,429 | Oct 17, 2022, 05:40 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Oct 10, 2022 | Sale | $37.99 | 5,000 | 189,950 | 77,073 | Oct 12, 2022, 04:59 PM | |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Oct 06, 2022 | Sale | $33.69 | 32,500 | 1,094,925 | 208,837 | Oct 07, 2022, 06:00 PM | |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President & CEO | Oct 03, 2022 | Sale | $16.92 | 20,000 | 338,428 | 320,148 | Oct 05, 2022, 08:55 AM | |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Sep 30, 2022 | Sale | $27.71 | 65,000 | 1,800,989 | 243,837 | Oct 04, 2022, 08:57 PM |
Menu